These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. How to build a biofilm: a fungal perspective. Blankenship JR; Mitchell AP Curr Opin Microbiol; 2006 Dec; 9(6):588-94. PubMed ID: 17055772 [TBL] [Abstract][Full Text] [Related]
7. Candida biofilm: a well-designed protected environment. Mukherjee PK; Zhou G; Munyon R; Ghannoum MA Med Mycol; 2005 May; 43(3):191-208. PubMed ID: 16010846 [TBL] [Abstract][Full Text] [Related]
8. Candida species isolated from different body sites and their antifungal susceptibility pattern: Cross-analysis of Candida albicans and Candida glabrata biofilms. Cataldi V; Di Campli E; Fazii P; Traini T; Cellini L; Di Giulio M Med Mycol; 2017 Aug; 55(6):624-634. PubMed ID: 27915303 [TBL] [Abstract][Full Text] [Related]
13. Variation in biofilm formation among blood and oral isolates of Candida albicans and Candida dubliniensis. Villar-Vidal M; Marcos-Arias C; Eraso E; Quindós G Enferm Infecc Microbiol Clin; 2011 Nov; 29(9):660-5. PubMed ID: 21899928 [TBL] [Abstract][Full Text] [Related]
15. Thymus vulgaris essential oil and thymol inhibit biofilms and interact synergistically with antifungal drugs against drug resistant strains of Candida albicans and Candida tropicalis. Jafri H; Ahmad I J Mycol Med; 2020 Apr; 30(1):100911. PubMed ID: 32008964 [TBL] [Abstract][Full Text] [Related]
16. Dispersion as an important step in the Candida albicans biofilm developmental cycle. Uppuluri P; Chaturvedi AK; Srinivasan A; Banerjee M; Ramasubramaniam AK; Köhler JR; Kadosh D; Lopez-Ribot JL PLoS Pathog; 2010 Mar; 6(3):e1000828. PubMed ID: 20360962 [TBL] [Abstract][Full Text] [Related]
17. Assessment and Optimizations of Candida albicans Lohse MB; Gulati M; Valle Arevalo A; Fishburn A; Johnson AD; Nobile CJ Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28289028 [No Abstract] [Full Text] [Related]
18. Biofilm matrix of Candida albicans and Candida tropicalis: chemical composition and role in drug resistance. Al-Fattani MA; Douglas LJ J Med Microbiol; 2006 Aug; 55(Pt 8):999-1008. PubMed ID: 16849719 [TBL] [Abstract][Full Text] [Related]
19. Development of Anti-Virulence Approaches for Candidiasis via a Novel Series of Small-Molecule Inhibitors of Romo JA; Pierce CG; Chaturvedi AK; Lazzell AL; McHardy SF; Saville SP; Lopez-Ribot JL mBio; 2017 Dec; 8(6):. PubMed ID: 29208749 [No Abstract] [Full Text] [Related]
20. Relative Abundances of Candida albicans and Candida glabrata in Olson ML; Jayaraman A; Kao KC Appl Environ Microbiol; 2018 Apr; 84(8):. PubMed ID: 29427422 [No Abstract] [Full Text] [Related] [Next] [New Search]